Clinical trial Recruiting at 7 sites Interventional Ages 60 to 80

Effect of heart procedure on thinking skills in older adults with mild cognitive impairment

Official title: EfFect of Ablation of Persistent AtriaL Fibrillation on COgNitive Function in Individuals With Mild Cognitive Impairment : - The FALCON Study-

Run by Poitiers University Hospital · NCT05790707 · Data updated 2026-11-12

This study is testing if a heart procedure combined with medication can help improve thinking skills in older adults with mild cognitive impairment.

More Mild Cognitive Impairment trials

Quick facts

Study typeInterventional
Ages60 Years to 80 Years
SexAll
Enrollment120 (estimated)
SponsorPoitiers University Hospital
Academic / other
Locations8 sites (Angers and 7 other locations)
StatusRecruiting
StartedApril 21, 2023
Main results expectedJanuary 2027
Study endsJuly 2027
Registry record updatedJanuary 23, 2026
Trial IDNCT05790707 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 60 to 85 with persistent atrial fibrillation and mild cognitive impairment.

Probably not a fit

Patients with a history of clinical stroke or neurodegenerative diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to assess how catheter ablation of persistent atrial fibrillation impacts cognitive function in individuals aged 60 to 85 with mild cognitive impairment. Participants will be randomly assigned to receive either antiarrhythmic drugs alone or a combination of atrial fibrillation ablation and antiarrhythmic drugs. The study will evaluate cognitive changes using standardized assessments to determine the effectiveness of the intervention. The goal is to provide insights into the relationship between heart rhythm control and cognitive health.

Why it matters

Potential benefit: If successful, this study could improve cognitive function in patients with mild cognitive impairment by addressing underlying atrial fibrillation.

How similar studies have gone: While there is limited data on this specific approach, similar studies have suggested potential cognitive benefits from managing atrial fibrillation, making this a promising area of investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 60 to 80 years
* Persistent atrial fibrillation
* Patients with an indication for cardiac rhythm control.
* Montreal Cognitive Assessment score between 18 and 25 points corresponding to mild cognitive impairment
* Free subject, not under temporary or permanent guardianship and not subject to subordination
* Subject understanding and accepting the constraints of the study
* Patient covered by French national health insurance or benefiting from it through a third party
* Subject has given written consent to the study after having received clear and complete information

Exclusion Criteria:

* Impossibility to perform the neuropsychological evaluation (communication problems such as hearing loss or aphasia, language barrier)
* History of clinical stroke
* Presence of a bruit at carotid auscultation or history of severe carotid stenosis
* History or suspicion of neurodegenerative disease (Parkinson's disease, Alzheimer's disease, Huntington's disease and amyotrophic lateral sclerosis...), bipolar disorder, schizophrenia, severe depression or amyloidosis
* Patient with history of previous atrial fibrillation ablation
* Patient undergoing flutter ablation or atrial tachycardia ablation (not atrial fibrillation ablation)
* Contraindication to atrial fibrillation ablation (intracardiac thrombus, severe pulmonary hypertension, mechanical mitral valve prosthesis or contraindication to anticoagulation,…)
* Contraindication to antiarrhythmic drugs, or to implantable cardiac monitor
* Patient with very advanced persistent atrial fibrillation, i.e., for more than 3 years or with a left atrial diameter \>60 mm in parasternal long axis section or a left atrial volume \> 48ml/m2 in echocardiography
* Subject with a life expectancy of less than 24 months at study enrolment
* Inability to consent
* Persons benefiting from a reinforced protection, namely minors, persons deprived of liberty by a judicial or administrative decision, adults under legal protection, and finally patients in emergency situations
* Pregnant or breastfeeding women, women at age to procreate and not using effective contraception (hormonal/barrier: oral, parenteral, percutaneous implantable, intrauterine device, or surgical: tubal ligation, hysterectomy, total ovariectomy)

Where it's running

  • CHU Angers
    Angers, France
    Recruiting
  • University Hospital
    Brest, France
    Recruiting
  • University Hospital
    Caen, France
    Recruiting
  • University Hospital
    Dijon, France
    Recruiting
  • CHU Grenoble
    Grenoble, France
    Recruiting
  • La Timone
    Marseille, France
    Recruiting
Show 2 more locations
  • University Hospital
    Poitiers, France
    Recruiting
  • Centre Cardiologique du Nord
    Saint-Denis, France
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.